{ "company_number": "07085029", "name": "GM Pharmasolutions Ltd", "url": "/company/07085029", "status": "Active", "is_active": true, "company_type": "Private Limited Company", "incorporated_on": "2009-11-24", "dissolved_on": null, "sic_codes": [ { "code": "74909", "description": "Other professional, scientific and technical activities n.e.c.", "section": "M", "section_name": "Professional, scientific and technical activities", "url": "/sic/74909" } ], "registered_address": { "id": 2029335, "url": "/address/2029335", "line1": "714 LONDON ROAD", "line2": "LARKFIELD", "post_town": "AYLESFORD", "county": "KENT", "country": "UNITED KINGDOM", "postcode": "ME20 6BL" }, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/07085029", "previous_names": [], "care_of": "", "po_box": "", "country_of_origin": "United Kingdom", "accounts": { "next_due": "2027-08-31", "last_made_up": "2025-11-30", "category": "TOTAL EXEMPTION FULL", "filings": [ { "url": "/company/07085029/accounts/2025-11-30", "pdf_url": "/company/07085029/accounts/2025-11-30.pdf", "made_up_date": "2025-11-30", "period_start": "2025-11-30", "period_end": "2025-11-30", "entity_name": "GM Pharmasolutions Ltd.", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "446.00", "debtors": "43264.00", "cash_bank_in_hand": "10383.00", "current_assets": "53647.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "11830.00", "total_assets_less_current_liabilities": "12276.00", "net_assets_liabilities": "12192.00", "called_up_share_capital": "2.00", "profit_loss_account_reserve": "12190.00", "shareholder_funds": "2.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Bulk_Data-2026-08-28.zip" }, { "url": "/company/07085029/accounts/2024-11-30", "pdf_url": "/company/07085029/accounts/2024-11-30.pdf", "made_up_date": "2024-11-30", "period_start": "2024-11-30", "period_end": "2024-11-30", "entity_name": "GM Pharmasolutions Ltd.", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "372.00", "debtors": "54371.00", "cash_bank_in_hand": "22894.00", "current_assets": "77265.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "652.00", "total_assets_less_current_liabilities": "1024.00", "net_assets_liabilities": "660.00", "called_up_share_capital": "2.00", "profit_loss_account_reserve": "658.00", "shareholder_funds": "2.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-August2025.zip" }, { "url": "/company/07085029/accounts/2023-11-30", "pdf_url": "/company/07085029/accounts/2023-11-30.pdf", "made_up_date": "2023-11-30", "period_start": "2023-11-30", "period_end": "2023-11-30", "entity_name": "GM Pharmasolutions Ltd.", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "1518.00", "debtors": "69073.00", "cash_bank_in_hand": "6105.00", "current_assets": "75178.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-606.00", "total_assets_less_current_liabilities": "912.00", "net_assets_liabilities": "261.00", "called_up_share_capital": "2.00", "profit_loss_account_reserve": "259.00", "shareholder_funds": "2.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2024.zip" }, { "url": "/company/07085029/accounts/2022-11-30", "pdf_url": "/company/07085029/accounts/2022-11-30.pdf", "made_up_date": "2022-11-30", "period_start": "2022-11-30", "period_end": "2022-11-30", "entity_name": "GM Pharmasolutions Ltd.", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "1915.00", "debtors": "23088.00", "cash_bank_in_hand": "19042.00", "current_assets": "42130.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-1310.00", "total_assets_less_current_liabilities": "605.00", "net_assets_liabilities": "241.00", "called_up_share_capital": "2.00", "profit_loss_account_reserve": "239.00", "shareholder_funds": "2.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-August2023.zip" }, { "url": "/company/07085029/accounts/2021-11-30", "pdf_url": "/company/07085029/accounts/2021-11-30.pdf", "made_up_date": "2021-11-30", "period_start": "2021-11-30", "period_end": "2021-11-30", "entity_name": "GM Pharmasolutions Ltd.", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "2874.00", "debtors": "5359.00", "cash_bank_in_hand": "97056.00", "current_assets": "102415.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "17760.00", "total_assets_less_current_liabilities": "20634.00", "net_assets_liabilities": "19829.00", "called_up_share_capital": "2.00", "profit_loss_account_reserve": "19827.00", "shareholder_funds": "2.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2022.zip" }, { "url": "/company/07085029/accounts/2020-11-30", "pdf_url": "/company/07085029/accounts/2020-11-30.pdf", "made_up_date": "2020-11-30", "period_start": "2020-11-30", "period_end": "2020-11-30", "entity_name": "GM Pharmasolutions Ltd.", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "1362.00", "debtors": "20567.00", "cash_bank_in_hand": "17404.00", "current_assets": "37971.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-654.00", "total_assets_less_current_liabilities": "708.00", "net_assets_liabilities": "449.00", "called_up_share_capital": "2.00", "profit_loss_account_reserve": "447.00", "shareholder_funds": "2.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2022.zip" }, { "url": "/company/07085029/accounts/2019-11-30", "pdf_url": "/company/07085029/accounts/2019-11-30.pdf", "made_up_date": "2019-11-30", "period_start": "2019-11-30", "period_end": "2019-11-30", "entity_name": "GM Pharmasolutions Ltd.", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "830.00", "debtors": "44100.00", "cash_bank_in_hand": "17968.00", "current_assets": "62068.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-573.00", "total_assets_less_current_liabilities": "257.00", "net_assets_liabilities": "99.00", "called_up_share_capital": "2.00", "profit_loss_account_reserve": "97.00", "shareholder_funds": "2.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2020.zip" }, { "url": "/company/07085029/accounts/2018-11-30", "pdf_url": "/company/07085029/accounts/2018-11-30.pdf", "made_up_date": "2018-11-30", "period_start": "2018-11-30", "period_end": "2018-11-30", "entity_name": "GM Pharmasolutions Ltd.", "dormant": false, "average_employees": null, "tangible_fixed_assets": "706.00", "debtors": "46980.00", "cash_bank_in_hand": "2825.00", "current_assets": "49805.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-123.00", "total_assets_less_current_liabilities": "583.00", "net_assets_liabilities": "452.00", "called_up_share_capital": "2.00", "profit_loss_account_reserve": "450.00", "shareholder_funds": "2.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-January2020.zip" }, { "url": "/company/07085029/accounts/2017-11-30", "pdf_url": "/company/07085029/accounts/2017-11-30.pdf", "made_up_date": "2017-11-30", "period_start": "2017-11-30", "period_end": "2017-11-30", "entity_name": "GM Pharmasolutions Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "2.00", "debtors": "17487.00", "cash_bank_in_hand": "17251.00", "current_assets": "34738.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "377.00", "total_assets_less_current_liabilities": "379.00", "net_assets_liabilities": null, "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "2.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-October2018.zip" }, { "url": "/company/07085029/accounts/2016-11-30", "pdf_url": "/company/07085029/accounts/2016-11-30.pdf", "made_up_date": "2016-11-30", "period_start": "2016-11-30", "period_end": "2016-11-30", "entity_name": "GM Pharmasolutions Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": "2.00", "debtors": "17175.00", "cash_bank_in_hand": null, "current_assets": "17175.00", "creditors_due_within_one_year": "19611.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-2436.00", "total_assets_less_current_liabilities": "-2434.00", "net_assets_liabilities": "-2434.00", "called_up_share_capital": "2.00", "profit_loss_account_reserve": "-2436.00", "shareholder_funds": "-2434.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2017.zip" }, { "url": "/company/07085029/accounts/2015-11-30", "pdf_url": "/company/07085029/accounts/2015-11-30.pdf", "made_up_date": "2015-11-30", "period_start": "2015-11-30", "period_end": "2015-11-30", "entity_name": "GM Pharmasolutions Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": "2.00", "debtors": "20700.00", "cash_bank_in_hand": null, "current_assets": "20700.00", "creditors_due_within_one_year": "22922.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-2222.00", "total_assets_less_current_liabilities": "-2220.00", "net_assets_liabilities": "-2220.00", "called_up_share_capital": "2.00", "profit_loss_account_reserve": "-2222.00", "shareholder_funds": "-2220.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2017.zip" }, { "url": "/company/07085029/accounts/2014-11-30", "pdf_url": "/company/07085029/accounts/2014-11-30.pdf", "made_up_date": "2014-11-30", "period_start": "2014-11-30", "period_end": "2014-11-30", "entity_name": "GM Pharmasolutions Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": "272.00", "debtors": "21415.00", "cash_bank_in_hand": null, "current_assets": "21415.00", "creditors_due_within_one_year": "21642.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-227.00", "total_assets_less_current_liabilities": "45.00", "net_assets_liabilities": "45.00", "called_up_share_capital": "2.00", "profit_loss_account_reserve": "43.00", "shareholder_funds": "45.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2015.zip" }, { "url": "/company/07085029/accounts/2013-11-30", "pdf_url": "/company/07085029/accounts/2013-11-30.pdf", "made_up_date": "2013-11-30", "period_start": "2013-11-30", "period_end": "2013-11-30", "entity_name": "GM Pharmasolutions Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": "207.00", "debtors": "6155.00", "cash_bank_in_hand": "6897.00", "current_assets": "13052.00", "creditors_due_within_one_year": "13099.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-47.00", "total_assets_less_current_liabilities": "160.00", "net_assets_liabilities": "160.00", "called_up_share_capital": "2.00", "profit_loss_account_reserve": "158.00", "shareholder_funds": "160.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-October2014.zip" }, { "url": "/company/07085029/accounts/2012-11-30", "pdf_url": "/company/07085029/accounts/2012-11-30.pdf", "made_up_date": "2012-11-30", "period_start": "2012-11-30", "period_end": "2012-11-30", "entity_name": "GM Pharmasolutions Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": "518.00", "debtors": "13928.00", "cash_bank_in_hand": "156.00", "current_assets": "14084.00", "creditors_due_within_one_year": "9755.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "4329.00", "total_assets_less_current_liabilities": "4847.00", "net_assets_liabilities": "4847.00", "called_up_share_capital": "2.00", "profit_loss_account_reserve": "4845.00", "shareholder_funds": "4847.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-August2013.zip" }, { "url": "/company/07085029/accounts/2011-11-30", "pdf_url": "/company/07085029/accounts/2011-11-30.pdf", "made_up_date": "2011-11-30", "period_start": "2011-11-30", "period_end": "2011-11-30", "entity_name": "GM Pharmasolutions Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": "830.00", "debtors": "6524.00", "cash_bank_in_hand": "4171.00", "current_assets": "10695.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-753.00", "total_assets_less_current_liabilities": "77.00", "net_assets_liabilities": "77.00", "called_up_share_capital": "2.00", "profit_loss_account_reserve": "75.00", "shareholder_funds": "77.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "xml", "parse_error": "", "source_zip": "Accounts_Monthly_Data-August2012.zip" }, { "url": "/company/07085029/accounts/2010-11-30", "pdf_url": "/company/07085029/accounts/2010-11-30.pdf", "made_up_date": "2010-11-30", "period_start": "2010-11-30", "period_end": "2010-11-30", "entity_name": "GM Pharmasolutions Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": "318.00", "debtors": null, "cash_bank_in_hand": "8989.00", "current_assets": "8989.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "108.00", "total_assets_less_current_liabilities": "426.00", "net_assets_liabilities": "426.00", "called_up_share_capital": "2.00", "profit_loss_account_reserve": "424.00", "shareholder_funds": "426.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "xml", "parse_error": "", "source_zip": "Accounts_Monthly_Data-August2011.zip" } ], "pdf_only_filings": [], "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/07085029/filing-history" }, "confirmation_statement": { "next_due": "2026-12-01", "last_made_up": "2025-11-17" }, "officers": [], "psc": [ { "name": "Mrs Georgina Pickering", "kind": "individual-person-with-significant-control", "person_url": "/person/1696772", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent" ], "notified_on": "2016-04-06", "ceased_on": null, "nationality": "British", "country_of_residence": "England", "source": "snapshot" }, { "name": "Mr. Mark Pickering", "kind": "individual-person-with-significant-control", "person_url": "/person/3146267", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent" ], "notified_on": "2016-04-06", "ceased_on": null, "nationality": "British", "country_of_residence": "United Kingdom", "source": "snapshot" } ], "external_links": [], "provenance": { "source": "snapshot", "first_seen_at": "2026-07-05T12:35:35.811816+00:00", "last_seen_snapshot": "2026-09-01", "retrieved_at": "2026-09-13T04:32:18.465226+00:00" }, "licence": "Open Government Licence v3.0", "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House." }